Goldman Sachs Group »

Psyence Biomedical shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Psyence Biomedical (PBMWW) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Psyence Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Psyence Biomedical held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Psyence Biomedical by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.1k 200k 0.01

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Alphabet CMN (GOOGL)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Visa CMN (V)
Ishares Tr CMN (EEM)

View all positions for Goldman Sachs Group

Top funds holding Psyence Biomedical

Cowen And Company
Polar Securities
MMCAP International Inc. SPC
Calamos Advisors
Cantor Fitzgerald, L. P.
Saba Capital Management
Clear Street Derivatives
Aristeia Capital
Context Capital Management
Periscope Capital
Goldman Sachs Group
LMR Partners
Clear Street
D. E. Shaw & Co
Tenor Capital Management

View all funds holding Psyence Biomedical